Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
AGNC Investment
AGNC
$12.6B
| $751K | ﹤0.01% |
74,121
-297,827
| -80% | -$2.89M |
|
1552
Powell Industries
POWL
$8B
| $745K | ﹤0.01% |
+36,900
| New | +$639K |
|
1553
iShares MSCI Canada ETF
EWC
$6.16B
| $737K | ﹤0.01% |
+21,058
| New | +$729K |
|
1554
Dollar General
DG
$28.2B
| $737K | ﹤0.01% |
4,339
-1,796,170
| -100% | -$355M |
|
1555
Caesars Entertainment
CZR
$6.06B
| $731K | ﹤0.01% |
14,341
-3,672
| -20% | -$167K |
|
1556
Penske Automotive Group
PAG
$14.3B
| $729K | ﹤0.01% |
4,375
+452
| +12% | +$65.6K |
|
1557
Ginkgo Bioworks
DNA
$584M
| $728K | ﹤0.01% |
9,783
-3,041
| -24% | -$180K |
|
1558
Harmony Gold Mining
HMY
$10.3B
| $728K | ﹤0.01% |
173,225
+152,820
| +749% | +$704K |
|
|
AYX
1559
DELISTED
Alteryx Inc
AYX
| $719K | ﹤0.01% |
15,829
+2,546
| +19% | +$112K |
|
|
SMAR
1560
DELISTED
Smartsheet Inc.
SMAR
| $706K | ﹤0.01% |
+18,446
| New | +$798K |
|
1561
Loews
L
$23.8B
| $705K | ﹤0.01% |
11,872
-64,084
| -84% | -$3.71M |
|
1562
Upwork
UPWK
$1.18B
| $705K | ﹤0.01% |
75,471
+138
| +0.2% | +$1.25K |
|
1563
iShares MSCI Chile ETF
ECH
$1.03B
| $701K | ﹤0.01% |
24,025
| – | – |
|
|
DOO
1564
Bombardier Recreational Products
DOO
$4.53B
| $700K | ﹤0.01% |
+8,275
| New | +$628K |
|
|
YALA
1565
Yalla Group
YALA
$840M
| $699K | ﹤0.01% |
160,419
-119,952
| -43% | -$480K |
|
1566
Bunge Global
BG
$20.2B
| $687K | ﹤0.01% |
7,278
+2,742
| +60% | +$254K |
|
1567
Tenaya Therapeutics
TNYA
$158M
| $681K | ﹤0.01% |
+116,025
| New | +$674K |
|
1568
Check Point Software Technologies
CHKP
$12.6B
| $667K | ﹤0.01% |
5,311
+3,106
| +141% | +$391K |
|
1569
Invesco
IVZ
$13.6B
| $665K | ﹤0.01% |
39,537
+2,117
| +6% | +$34.1K |
|
1570
Mid-America Apartment Communities
MAA
$15.5B
| $664K | ﹤0.01% |
4,370
+2,412
| +123% | +$362K |
|
1571
iShares Russell 1000 Value ETF
IWD
$82.6B
| $663K | ﹤0.01% |
4,200
-119,695
| -97% | -$18.3M |
|
1572
Twist Bioscience
TWST
$6.29B
| $661K | ﹤0.01% |
+32,287
| New | +$484K |
|
1573
Factset
FDS
$9.59B
| $659K | ﹤0.01% |
1,644
-5,229
| -76% | -$2.11M |
|
1574
Clorox
CLX
$11.9B
| $654K | ﹤0.01% |
4,111
+754
| +22% | +$122K |
|
1575
Futu Holdings
FUTU
$15B
| $645K | ﹤0.01% |
16,235
+6,417
| +65% | +$273K |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.